These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 19699696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma].
    Reig M, Matilla A, Bustamante J, Castells L, de La Mata M, Delgado M, Moreno JM, Forner A, Varela M.
    Gastroenterol Hepatol; 2010 Dec; 33(10):741-52. PubMed ID: 20851505
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sorafenib in hepatocellular carcinoma.
    Josephs DH, Ross PJ.
    Br J Hosp Med (Lond); 2010 Aug; 71(8):451-6. PubMed ID: 20852487
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sorafenib for HCC: a pragmatic perspective.
    Razumilava N, Gores GJ.
    Oncology (Williston Park); 2011 Mar; 25(3):300, 302. PubMed ID: 21548475
    [No Abstract] [Full Text] [Related]

  • 9. Sorafenib for liver cancer: the horizon broadens.
    Johnson P, Billingham L.
    Lancet Oncol; 2009 Jan; 10(1):4-5. PubMed ID: 19111238
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sorafenib in advanced hepatocellular carcinoma.
    Copur MS.
    N Engl J Med; 2008 Dec 04; 359(23):2498; author reply 2498-9. PubMed ID: 19065701
    [No Abstract] [Full Text] [Related]

  • 13. [Hepatocellular carcinoma].
    Yamashita T, Arai K, Kaneko S.
    Nihon Rinsho; 2010 Oct 04; 68(10):1861-5. PubMed ID: 20954330
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?
    Kim DY, Han KH.
    J Gastroenterol Hepatol; 2011 Nov 04; 26(11):1585-6. PubMed ID: 22011294
    [No Abstract] [Full Text] [Related]

  • 19. Immune oncology in hepatocellular carcinoma-hype and hope.
    Wörns MA, Galle PR.
    Lancet; 2017 Jun 24; 389(10088):2448-2449. PubMed ID: 28434649
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.